Today there is no FDA approved drug for the treatment of fatty liver. However, clinicians make use of the available options in managing fatty liver. In this video Dr Ajay Kumar talks about the available and emerging trends in the pharmacological treatment of NAFLD/NASH
Dr. Ajay Kumar is a Chairman and HOD - Institute for Digestive and Liver Diseases at BLK Super Speciality Hospital, New Delhi. He completed MBBS from Punjab University, Chandigarh in 1980, MD - Medicine from Postgraduate Institute of Medical Education and Research, Chandigarh in 1984 and DM - Gastroenterology from the University of Delhi in 1987. Dr. Ajay has been awarded BC Roy Award from the President of India. He is an experienced clinician with a special interest in Pancreatico Biliary Disease, Luminal Gastroenterology and advanced Therapeutic Endoscopy. Dr. Ajay Kumar has more than forty publications in the national and international journals and more than 20 papers presented at Conference. He has contributed 17 Book Chapters. Before joining Fortis Hospital, Dr. Ajay Kumar has served in Indraprastha Apollo Hospital, G B Pant Hospital and other prestigious institutes.